PTEN regulates CTNNA1 expression by modifying the ratio of P42 CCAAT/enhancer binding protein (C/EBP) to P30 C/EBP, thereby affecting the progression of bone marrow dysplasia and AML. Here, CEBPA is linked to acute myeloid leukemia.